Tests for both Janus kinase mutation JAK2 V617F and rearrangement of the genes BCR-ABL1, platelet-derived growth factor receptor-? (PDGFR?), PDGFR?, and fibroblast growth factor receptor-1 (FGFR1) were negative. 